Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-08 5:00 pm Sale | 13G | F-STAR THERAPEUTICS INC FSTX | Merck KGaA | 75,140 0.1% | -418,570 (-84.78%) | View |
| 2021-02-16 06:05 am Sale | 13G | PROGYNY INC PGNY | Merck KGaA | 45,000 0.1% | -4,252,414 (-98.95%) | View |
| 2021-02-04 4:30 pm Unchanged | 13G | PROGYNY INC PGNY | Merck KGaA | 4,297,414 5.1% | 0 (Unchanged) | View |
| 2021-02-01 4:32 pm Purchase | 13G | F-STAR THERAPEUTICS INC FSTX | Merck KGaA | 493,710 5.4% | 493,710 (New Position) | View |
| 2020-02-11 4:29 pm Purchase | 13G | PROGYNY INC PGNY | Merck KGaA | 4,297,414 5.1% | 4,297,414 (New Position) | View |
| 2019-08-14 06:13 am Unchanged | 13D | INTERMOLECULAR INC IMI | Merck KGaA | 15,429,618 31% | 0 (Unchanged) | View |
| 2019-05-16 4:15 pm Purchase | 13D | INTERMOLECULAR INC IMI | Merck KGaA | 15,429,618 31% | 15,429,618 (New Position) | View |